CompletedPhase 2NCT06089265
Ketohexokinase Inhibition in Hereditary Fructose Intolerance
Studying Hereditary fructose intolerance
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Maastricht University Medical Center
- Principal Investigator
- Patrick Schrauwen, PhDMaastricht University
- Intervention
- PF-06801591(drug)
- Enrollment
- 8 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2023
Study locations (1)
- Maastricht University Medical centre, Maastricht, Limburg, Netherlands
Collaborators
Pfizer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06089265 on ClinicalTrials.gov